Rocket Pharmaceuticals stockholders elect directors, ratify auditor, approve say-on-pay and stock option exchange

ROCKET PHARMACEUTICALS, INC.

Seven director nominees elected; David P. Southwell received 43.2M for, 20.1M withheld (lowest support).
Ratification of EisnerAmper as independent auditor: 79.2M for, 1.0M against, 0.6M abstain.
Non-binding advisory vote on executive compensation approved: 61.4M for, 1.7M against, 0.2M abstain.
Stock option exchange program approved with 45.6M for, 17.6M against (significant opposition).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.